Multidimensional MRI for Sub-Voxel Traumatic Axon Injury Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current magnetic resonance imaging (MRI) methods struggle to accurately detect and assess mild traumatic brain injury (TBI), particularly due to their limited spatial resolution and inability to differentiate between normal and pathological tissue at the neuronal level.
Innovation Solution
The development of noninvasive multidimensional MRI-based methods that utilize unique traumatic axonal injury (TAI) multidimensional spectral signatures to generate biomarker images, allowing for the identification and categorization of sub-voxel tissue components specific to TAI lesions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional MRI methods are used for TBI detection, then the imaging process is simple and fast, but the spatial resolution is insufficient (above 400 μm) to detect neuronal-level injuries
Solution Approach 1:
The patent transitions from conventional single-contrast MRI to multidimensional MRI by incorporating multiple contrast mechanisms (T1-weighted, T2-weighted, diffusion-weighted, susceptibility-weighted, proton density) simultaneously. This dimensional expansion enables detection of TAI at neuronal levels (below 100 μm) while maintaining clinical feasibility through advanced signal processing and composite imaging techniques
2Measurement precision
If voxel-averaged MRI approaches are used, then the imaging process is straightforward, but the ability to separate normal and pathological tissue within a voxel is lost, leading to non-specific detection
Solution Approach 1:
The patent applies segmentation by decomposing each voxel's multidimensional signal into distinct tissue component contributions (normal tissue vs. pathological TAI tissue). Through multidimensional spectral analysis, the method separates overlapping signals from different tissue types within the same voxel, enabling specific identification of TAI lesions while filtering out normal tissue signals
Solution Approach 2:
The patent utilizes parameter changes by measuring multiple MRI parameters (T1 relaxation time, T2 relaxation time, diffusion coefficient, susceptibility, proton density) simultaneously for each voxel. This multidimensional parameter space allows differentiation of TAI tissue from normal tissue based on their distinct parameter signatures, overcoming the limitations of single-parameter voxel-averaged approaches
3Measurement precision
If DTI with FA metric is used for mTBI detection, then the spatial sensitivity is improved (below 100 μm), but the specificity is reduced due to conflicting observations of FA increases and decreases
Solution Approach 1:
The patent implements multi-functionality by employing a comprehensive multidimensional MRI framework that simultaneously performs multiple detection functions: T1 and T2 weighting for tissue composition analysis, diffusion-weighted imaging for microstructural integrity assessment, susceptibility-weighted imaging for hemorrhage detection, and proton density for overall tissue characterization. This multifunctional approach replaces the single-metric DTI-FA method, providing both high spatial sensitivity and reliable specificity through convergent evidence from multiple contrasts
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These methods enable precise identification and characterization of TAI lesions, correlating well with amyloid precursor protein (APP) histopathology, and providing noninvasive histology capabilities, thus improving the specificity and sensitivity of TBI assessment.
Implementation Method 1
magnetic resonance methods for detected injury, particularly traumatic brain injury
Data Source
AI summary
Multidimensional MRI-based methods permit identification and categorization of brain specimens to identify sub-voxel tissue components that are specific to traumatic axon injury or other lesions. Lower dimensional MR spectral data is acquired and processed to provide multidimensional MR data of higher dimensions. One or more spectral ranges are selected that define signatures for brain injury and evaluation of the multidimensional MR data in these ranges is used to locate voxels associated with brain injury. For example, partial one dimensional data sets such as T1, T2, and mean diffusion coefficient (MD) data sets can be combined to provide two dimensional data sets such as T1-T2, MD-T2, and MD-T1 data sets. Using the spectral signatures, a specimen image can be produced showing areas of lesser or greater injury.